Advances in biological sciences, combined with the accelerating development of artificial intelligence(AI), are fueling a new wave of innovation that could have significant impact in sectors across the economy, from healthcare and agriculture to consumer goods and energy.
With a market representing more than $600 million per year in the United States alone, the Consumer Goods industry is poised to be disrupted, from skincare with advanced bio-designed proteins to lab-grown leather leading the way to a more sustainable retail industry.
Climate tech companies are transforming the world’s largest markets with innovative sustainable alternatives. As political capital becomes more focused on policy change surrounding global warming, and consumers demanding climate responsibility from brands, sustainable products are seeing higher growth rates than their non-sustainable alternatives.
Drugs & Therapeutics is changing and with the exponential growth of the knowledge base on cells, we are discovering, evaluating, and validating drug targets and therapeutic candidates at a faster pace that advance the next generation of immunomodulatory drugs.
Though still in its infancy, the longevity ecosystem is already attracting an influx of funding from investors, academic institutions, and governments. With more than 50 longevity-focused companies raising more than $1 billion in venture funding as of 2020—a sizable amount that continues to rise due to the growing conviction that the longevity market could outstrip the existing health care market in the long run.
Our agriculture industry relies for now on the massive use of fertilizers which have a significant impact on both our health and the environment. Reinventing fertilizers, synthetic biology can be used to create living products based on soil microbes.
Biomanufacturing supported by single-use technologies has seen strong growth in the recent years and this was further accelerated during the pandemic crisis.
Improving on traditional technologies like low-throughput microscopy and electrophysiological and imaging approaches, genetic techniques open the window to the development of a range of tools dedicated to the recording, control and eventually repair of neural dynamics.